nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—OPRD1—Amitriptyline—migraine	0.0576	0.0766	CbGbCtD
Buprenorphine—CYP2C18—Valproic Acid—migraine	0.0525	0.0698	CbGbCtD
Buprenorphine—UGT1A9—Valproic Acid—migraine	0.0525	0.0698	CbGbCtD
Buprenorphine—OPRK1—Amitriptyline—migraine	0.0482	0.064	CbGbCtD
Buprenorphine—CYP2C18—Verapamil—migraine	0.0457	0.0608	CbGbCtD
Buprenorphine—OPRM1—Amitriptyline—migraine	0.0424	0.0564	CbGbCtD
Buprenorphine—CYP2A6—Valproic Acid—migraine	0.0255	0.0339	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Propranolol—migraine	0.0221	0.0294	CbGbCtD
Buprenorphine—CYP3A7—Propranolol—migraine	0.0221	0.0294	CbGbCtD
Buprenorphine—ABCG2—Verapamil—migraine	0.0205	0.0273	CbGbCtD
Buprenorphine—CYP3A5—Propranolol—migraine	0.0166	0.0221	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Verapamil—migraine	0.0152	0.0202	CbGbCtD
Buprenorphine—CYP3A7—Verapamil—migraine	0.0152	0.0202	CbGbCtD
Buprenorphine—CYP2C19—Timolol—migraine	0.015	0.02	CbGbCtD
Buprenorphine—CYP3A5—Amitriptyline—migraine	0.0143	0.0191	CbGbCtD
Buprenorphine—CYP2C8—Amitriptyline—migraine	0.0138	0.0183	CbGbCtD
Buprenorphine—CYP2C19—Propranolol—migraine	0.0134	0.0178	CbGbCtD
Buprenorphine—CYP3A5—Valproic Acid—migraine	0.0131	0.0174	CbGbCtD
Buprenorphine—CYP2C8—Valproic Acid—migraine	0.0126	0.0167	CbGbCtD
Buprenorphine—CYP1A2—Propranolol—migraine	0.0123	0.0164	CbGbCtD
Buprenorphine—ABCB1—Timolol—migraine	0.0121	0.0161	CbGbCtD
Buprenorphine—CYP2C19—Amitriptyline—migraine	0.0116	0.0154	CbGbCtD
Buprenorphine—CYP2D6—Timolol—migraine	0.0114	0.0152	CbGbCtD
Buprenorphine—CYP3A5—Verapamil—migraine	0.0114	0.0151	CbGbCtD
Buprenorphine—CYP2C8—Verapamil—migraine	0.0109	0.0146	CbGbCtD
Buprenorphine—ABCB1—Propranolol—migraine	0.0108	0.0144	CbGbCtD
Buprenorphine—CYP1A2—Amitriptyline—migraine	0.0107	0.0142	CbGbCtD
Buprenorphine—CYP2C19—Valproic Acid—migraine	0.0105	0.014	CbGbCtD
Buprenorphine—CYP2D6—Propranolol—migraine	0.0102	0.0135	CbGbCtD
Buprenorphine—CYP1A2—Valproic Acid—migraine	0.00973	0.0129	CbGbCtD
Buprenorphine—CYP2C9—Amitriptyline—migraine	0.00962	0.0128	CbGbCtD
Buprenorphine—CYP2C19—Topiramate—migraine	0.00952	0.0127	CbGbCtD
Buprenorphine—ABCB1—Amitriptyline—migraine	0.00934	0.0124	CbGbCtD
Buprenorphine—CYP2C19—Verapamil—migraine	0.00918	0.0122	CbGbCtD
Buprenorphine—CYP2D6—Amitriptyline—migraine	0.0088	0.0117	CbGbCtD
Buprenorphine—CYP2C9—Valproic Acid—migraine	0.00877	0.0117	CbGbCtD
Buprenorphine—CYP1A2—Verapamil—migraine	0.00847	0.0113	CbGbCtD
Buprenorphine—CYP2C9—Verapamil—migraine	0.00763	0.0102	CbGbCtD
Buprenorphine—ABCB1—Verapamil—migraine	0.00741	0.00986	CbGbCtD
Buprenorphine—CYP2D6—Verapamil—migraine	0.00698	0.00929	CbGbCtD
Buprenorphine—CYP3A4—Propranolol—migraine	0.00647	0.0086	CbGbCtD
Buprenorphine—CYP3A4—Amitriptyline—migraine	0.00559	0.00744	CbGbCtD
Buprenorphine—CYP3A4—Valproic Acid—migraine	0.0051	0.00678	CbGbCtD
Buprenorphine—CYP3A4—Topiramate—migraine	0.0046	0.00612	CbGbCtD
Buprenorphine—CYP3A4—Verapamil—migraine	0.00444	0.0059	CbGbCtD
Buprenorphine—Naloxone—ESR1—migraine	0.000714	1	CrCbGaD
Buprenorphine—OPRL1—brainstem—migraine	0.000542	0.107	CbGeAlD
Buprenorphine—OPRM1—nerve—migraine	0.000444	0.0875	CbGeAlD
Buprenorphine—OPRL1—head—migraine	0.000299	0.0591	CbGeAlD
Buprenorphine—OPRL1—nervous system—migraine	0.000284	0.056	CbGeAlD
Buprenorphine—OPRL1—central nervous system—migraine	0.000273	0.0539	CbGeAlD
Buprenorphine—OPRL1—brain—migraine	0.000217	0.0428	CbGeAlD
Buprenorphine—OPRM1—brainstem—migraine	0.00019	0.0376	CbGeAlD
Buprenorphine—Vision blurred—Timolol—migraine	0.000158	0.000784	CcSEcCtD
Buprenorphine—Sinusitis—Topiramate—migraine	0.000158	0.000782	CcSEcCtD
Buprenorphine—Mental disorder—Gabapentin—migraine	0.000157	0.00078	CcSEcCtD
Buprenorphine—Dry mouth—Valproic Acid—migraine	0.000157	0.000778	CcSEcCtD
Buprenorphine—Malnutrition—Gabapentin—migraine	0.000156	0.000775	CcSEcCtD
Buprenorphine—Erythema—Gabapentin—migraine	0.000156	0.000775	CcSEcCtD
Buprenorphine—Dizziness—Propranolol—migraine	0.000156	0.000773	CcSEcCtD
Buprenorphine—Asthenia—Verapamil—migraine	0.000155	0.000772	CcSEcCtD
Buprenorphine—Confusional state—Valproic Acid—migraine	0.000155	0.000769	CcSEcCtD
Buprenorphine—OPRD1—head—migraine	0.000154	0.0304	CbGeAlD
Buprenorphine—Flatulence—Gabapentin—migraine	0.000154	0.000763	CcSEcCtD
Buprenorphine—Anaphylactic shock—Valproic Acid—migraine	0.000154	0.000763	CcSEcCtD
Buprenorphine—Oedema—Valproic Acid—migraine	0.000154	0.000763	CcSEcCtD
Buprenorphine—Bradycardia—Topiramate—migraine	0.000154	0.000762	CcSEcCtD
Buprenorphine—Pruritus—Verapamil—migraine	0.000153	0.000761	CcSEcCtD
Buprenorphine—Tension—Gabapentin—migraine	0.000153	0.00076	CcSEcCtD
Buprenorphine—Angioedema—Timolol—migraine	0.000153	0.00076	CcSEcCtD
Buprenorphine—Dysgeusia—Gabapentin—migraine	0.000153	0.000759	CcSEcCtD
Buprenorphine—Infection—Valproic Acid—migraine	0.000153	0.000758	CcSEcCtD
Buprenorphine—Nervousness—Gabapentin—migraine	0.000152	0.000752	CcSEcCtD
Buprenorphine—Rhinitis—Topiramate—migraine	0.000151	0.000751	CcSEcCtD
Buprenorphine—Back pain—Gabapentin—migraine	0.000151	0.000749	CcSEcCtD
Buprenorphine—Nervous system disorder—Valproic Acid—migraine	0.000151	0.000748	CcSEcCtD
Buprenorphine—Vertigo—Timolol—migraine	0.000151	0.000747	CcSEcCtD
Buprenorphine—Syncope—Timolol—migraine	0.00015	0.000746	CcSEcCtD
Buprenorphine—Hallucination—Topiramate—migraine	0.00015	0.000745	CcSEcCtD
Buprenorphine—Hypoaesthesia—Topiramate—migraine	0.00015	0.000745	CcSEcCtD
Buprenorphine—Muscle spasms—Gabapentin—migraine	0.00015	0.000745	CcSEcCtD
Buprenorphine—Tachycardia—Valproic Acid—migraine	0.00015	0.000744	CcSEcCtD
Buprenorphine—Vomiting—Propranolol—migraine	0.00015	0.000743	CcSEcCtD
Buprenorphine—Pharyngitis—Topiramate—migraine	0.00015	0.000743	CcSEcCtD
Buprenorphine—Skin disorder—Valproic Acid—migraine	0.000149	0.000741	CcSEcCtD
Buprenorphine—Urinary tract disorder—Topiramate—migraine	0.000149	0.000739	CcSEcCtD
Buprenorphine—Oedema peripheral—Topiramate—migraine	0.000149	0.000738	CcSEcCtD
Buprenorphine—Hyperhidrosis—Valproic Acid—migraine	0.000149	0.000737	CcSEcCtD
Buprenorphine—Rash—Propranolol—migraine	0.000149	0.000737	CcSEcCtD
Buprenorphine—Dermatitis—Propranolol—migraine	0.000148	0.000737	CcSEcCtD
Buprenorphine—Diarrhoea—Verapamil—migraine	0.000148	0.000736	CcSEcCtD
Buprenorphine—Connective tissue disorder—Topiramate—migraine	0.000148	0.000736	CcSEcCtD
Buprenorphine—Palpitations—Timolol—migraine	0.000148	0.000735	CcSEcCtD
Buprenorphine—OPRK1—head—migraine	0.000148	0.0292	CbGeAlD
Buprenorphine—Urethral disorder—Topiramate—migraine	0.000148	0.000734	CcSEcCtD
Buprenorphine—Loss of consciousness—Timolol—migraine	0.000147	0.000731	CcSEcCtD
Buprenorphine—Vision blurred—Gabapentin—migraine	0.000147	0.00073	CcSEcCtD
Buprenorphine—Anorexia—Valproic Acid—migraine	0.000146	0.000727	CcSEcCtD
Buprenorphine—OPRD1—nervous system—migraine	0.000146	0.0289	CbGeAlD
Buprenorphine—Cough—Timolol—migraine	0.000146	0.000726	CcSEcCtD
Buprenorphine—Tremor—Gabapentin—migraine	0.000146	0.000726	CcSEcCtD
Buprenorphine—Visual impairment—Topiramate—migraine	0.000145	0.000721	CcSEcCtD
Buprenorphine—Ill-defined disorder—Gabapentin—migraine	0.000145	0.000719	CcSEcCtD
Buprenorphine—Hypertension—Timolol—migraine	0.000145	0.000718	CcSEcCtD
Buprenorphine—Hypotension—Valproic Acid—migraine	0.000144	0.000713	CcSEcCtD
Buprenorphine—Agitation—Gabapentin—migraine	0.000143	0.000712	CcSEcCtD
Buprenorphine—Dizziness—Verapamil—migraine	0.000143	0.000711	CcSEcCtD
Buprenorphine—Myalgia—Timolol—migraine	0.000143	0.000708	CcSEcCtD
Buprenorphine—Chest pain—Timolol—migraine	0.000143	0.000708	CcSEcCtD
Buprenorphine—Arthralgia—Timolol—migraine	0.000143	0.000708	CcSEcCtD
Buprenorphine—Angioedema—Gabapentin—migraine	0.000143	0.000708	CcSEcCtD
Buprenorphine—Anxiety—Timolol—migraine	0.000142	0.000706	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000142	0.000703	CcSEcCtD
Buprenorphine—Discomfort—Timolol—migraine	0.000141	0.0007	CcSEcCtD
Buprenorphine—Eye disorder—Topiramate—migraine	0.000141	0.0007	CcSEcCtD
Buprenorphine—OPRD1—central nervous system—migraine	0.000141	0.0278	CbGeAlD
Buprenorphine—Malaise—Gabapentin—migraine	0.000141	0.000699	CcSEcCtD
Buprenorphine—Tinnitus—Topiramate—migraine	0.000141	0.000698	CcSEcCtD
Buprenorphine—OPRK1—nervous system—migraine	0.00014	0.0277	CbGeAlD
Buprenorphine—Vertigo—Gabapentin—migraine	0.00014	0.000696	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Valproic Acid—migraine	0.00014	0.000695	CcSEcCtD
Buprenorphine—Flushing—Topiramate—migraine	0.00014	0.000695	CcSEcCtD
Buprenorphine—Cardiac disorder—Topiramate—migraine	0.00014	0.000695	CcSEcCtD
Buprenorphine—Syncope—Gabapentin—migraine	0.00014	0.000695	CcSEcCtD
Buprenorphine—Nausea—Propranolol—migraine	0.00014	0.000695	CcSEcCtD
Buprenorphine—Dry mouth—Timolol—migraine	0.00014	0.000693	CcSEcCtD
Buprenorphine—Insomnia—Valproic Acid—migraine	0.000139	0.00069	CcSEcCtD
Buprenorphine—Paraesthesia—Valproic Acid—migraine	0.000138	0.000685	CcSEcCtD
Buprenorphine—Palpitations—Gabapentin—migraine	0.000138	0.000685	CcSEcCtD
Buprenorphine—Confusional state—Timolol—migraine	0.000138	0.000685	CcSEcCtD
Buprenorphine—Vomiting—Verapamil—migraine	0.000138	0.000684	CcSEcCtD
Buprenorphine—Loss of consciousness—Gabapentin—migraine	0.000137	0.000681	CcSEcCtD
Buprenorphine—Dyspnoea—Valproic Acid—migraine	0.000137	0.00068	CcSEcCtD
Buprenorphine—Angiopathy—Topiramate—migraine	0.000137	0.000679	CcSEcCtD
Buprenorphine—Oedema—Timolol—migraine	0.000137	0.000679	CcSEcCtD
Buprenorphine—Anaphylactic shock—Timolol—migraine	0.000137	0.000679	CcSEcCtD
Buprenorphine—Rash—Verapamil—migraine	0.000137	0.000678	CcSEcCtD
Buprenorphine—Somnolence—Valproic Acid—migraine	0.000137	0.000678	CcSEcCtD
Buprenorphine—Dermatitis—Verapamil—migraine	0.000136	0.000678	CcSEcCtD
Buprenorphine—Immune system disorder—Topiramate—migraine	0.000136	0.000676	CcSEcCtD
Buprenorphine—Cough—Gabapentin—migraine	0.000136	0.000676	CcSEcCtD
Buprenorphine—Mediastinal disorder—Topiramate—migraine	0.000136	0.000675	CcSEcCtD
Buprenorphine—Infection—Timolol—migraine	0.000136	0.000674	CcSEcCtD
Buprenorphine—Headache—Verapamil—migraine	0.000136	0.000674	CcSEcCtD
Buprenorphine—Chills—Topiramate—migraine	0.000135	0.000672	CcSEcCtD
Buprenorphine—Dyspepsia—Valproic Acid—migraine	0.000135	0.000671	CcSEcCtD
Buprenorphine—Convulsion—Gabapentin—migraine	0.000135	0.000671	CcSEcCtD
Buprenorphine—OPRK1—central nervous system—migraine	0.000135	0.0266	CbGeAlD
Buprenorphine—Hypertension—Gabapentin—migraine	0.000135	0.000669	CcSEcCtD
Buprenorphine—Shock—Timolol—migraine	0.000135	0.000668	CcSEcCtD
Buprenorphine—Nervous system disorder—Timolol—migraine	0.000134	0.000666	CcSEcCtD
Buprenorphine—Decreased appetite—Valproic Acid—migraine	0.000134	0.000663	CcSEcCtD
Buprenorphine—Chest pain—Gabapentin—migraine	0.000133	0.00066	CcSEcCtD
Buprenorphine—Arthralgia—Gabapentin—migraine	0.000133	0.00066	CcSEcCtD
Buprenorphine—Myalgia—Gabapentin—migraine	0.000133	0.00066	CcSEcCtD
Buprenorphine—Skin disorder—Timolol—migraine	0.000133	0.000659	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Valproic Acid—migraine	0.000133	0.000658	CcSEcCtD
Buprenorphine—Fatigue—Valproic Acid—migraine	0.000132	0.000658	CcSEcCtD
Buprenorphine—Anxiety—Gabapentin—migraine	0.000132	0.000657	CcSEcCtD
Buprenorphine—Hyperhidrosis—Timolol—migraine	0.000132	0.000656	CcSEcCtD
Buprenorphine—Mental disorder—Topiramate—migraine	0.000132	0.000656	CcSEcCtD
Buprenorphine—OPRK1—cerebellum—migraine	0.000132	0.026	CbGeAlD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000132	0.000655	CcSEcCtD
Buprenorphine—Constipation—Valproic Acid—migraine	0.000131	0.000652	CcSEcCtD
Buprenorphine—Pain—Valproic Acid—migraine	0.000131	0.000652	CcSEcCtD
Buprenorphine—Erythema—Topiramate—migraine	0.000131	0.000652	CcSEcCtD
Buprenorphine—Malnutrition—Topiramate—migraine	0.000131	0.000652	CcSEcCtD
Buprenorphine—Discomfort—Gabapentin—migraine	0.000131	0.000652	CcSEcCtD
Buprenorphine—Anorexia—Timolol—migraine	0.00013	0.000647	CcSEcCtD
Buprenorphine—Dry mouth—Gabapentin—migraine	0.00013	0.000645	CcSEcCtD
Buprenorphine—Flatulence—Topiramate—migraine	0.000129	0.000642	CcSEcCtD
Buprenorphine—Tension—Topiramate—migraine	0.000129	0.00064	CcSEcCtD
Buprenorphine—Nausea—Verapamil—migraine	0.000129	0.000639	CcSEcCtD
Buprenorphine—Dysgeusia—Topiramate—migraine	0.000129	0.000638	CcSEcCtD
Buprenorphine—Confusional state—Gabapentin—migraine	0.000128	0.000637	CcSEcCtD
Buprenorphine—Hypotension—Timolol—migraine	0.000128	0.000634	CcSEcCtD
Buprenorphine—Nervousness—Topiramate—migraine	0.000128	0.000633	CcSEcCtD
Buprenorphine—Anaphylactic shock—Gabapentin—migraine	0.000127	0.000632	CcSEcCtD
Buprenorphine—Oedema—Gabapentin—migraine	0.000127	0.000632	CcSEcCtD
Buprenorphine—Back pain—Topiramate—migraine	0.000127	0.00063	CcSEcCtD
Buprenorphine—Feeling abnormal—Valproic Acid—migraine	0.000127	0.000628	CcSEcCtD
Buprenorphine—Infection—Gabapentin—migraine	0.000127	0.000628	CcSEcCtD
Buprenorphine—Muscle spasms—Topiramate—migraine	0.000126	0.000627	CcSEcCtD
Buprenorphine—ABCG2—trigeminal ganglion—migraine	0.000126	0.0248	CbGeAlD
Buprenorphine—Gastrointestinal pain—Valproic Acid—migraine	0.000126	0.000624	CcSEcCtD
Buprenorphine—Shock—Gabapentin—migraine	0.000125	0.000622	CcSEcCtD
Buprenorphine—Nervous system disorder—Gabapentin—migraine	0.000125	0.00062	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Timolol—migraine	0.000125	0.000619	CcSEcCtD
Buprenorphine—Tachycardia—Gabapentin—migraine	0.000124	0.000617	CcSEcCtD
Buprenorphine—Vision blurred—Topiramate—migraine	0.000124	0.000614	CcSEcCtD
Buprenorphine—Skin disorder—Gabapentin—migraine	0.000124	0.000614	CcSEcCtD
Buprenorphine—Insomnia—Timolol—migraine	0.000124	0.000614	CcSEcCtD
Buprenorphine—Hyperhidrosis—Gabapentin—migraine	0.000123	0.000611	CcSEcCtD
Buprenorphine—Tremor—Topiramate—migraine	0.000123	0.000611	CcSEcCtD
Buprenorphine—Paraesthesia—Timolol—migraine	0.000123	0.00061	CcSEcCtD
Buprenorphine—Urticaria—Valproic Acid—migraine	0.000122	0.000606	CcSEcCtD
Buprenorphine—Dyspnoea—Timolol—migraine	0.000122	0.000605	CcSEcCtD
Buprenorphine—Ill-defined disorder—Topiramate—migraine	0.000122	0.000605	CcSEcCtD
Buprenorphine—Somnolence—Timolol—migraine	0.000122	0.000604	CcSEcCtD
Buprenorphine—Abdominal pain—Valproic Acid—migraine	0.000121	0.000603	CcSEcCtD
Buprenorphine—Body temperature increased—Valproic Acid—migraine	0.000121	0.000603	CcSEcCtD
Buprenorphine—Anorexia—Gabapentin—migraine	0.000121	0.000603	CcSEcCtD
Buprenorphine—Agitation—Topiramate—migraine	0.000121	0.000599	CcSEcCtD
Buprenorphine—Dyspepsia—Timolol—migraine	0.00012	0.000598	CcSEcCtD
Buprenorphine—Hypotension—Gabapentin—migraine	0.000119	0.000591	CcSEcCtD
Buprenorphine—Decreased appetite—Timolol—migraine	0.000119	0.00059	CcSEcCtD
Buprenorphine—Malaise—Topiramate—migraine	0.000118	0.000588	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Timolol—migraine	0.000118	0.000586	CcSEcCtD
Buprenorphine—Vertigo—Topiramate—migraine	0.000118	0.000586	CcSEcCtD
Buprenorphine—Fatigue—Timolol—migraine	0.000118	0.000585	CcSEcCtD
Buprenorphine—Syncope—Topiramate—migraine	0.000118	0.000584	CcSEcCtD
Buprenorphine—Pain—Timolol—migraine	0.000117	0.000581	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Gabapentin—migraine	0.000116	0.000576	CcSEcCtD
Buprenorphine—Palpitations—Topiramate—migraine	0.000116	0.000576	CcSEcCtD
Buprenorphine—Loss of consciousness—Topiramate—migraine	0.000115	0.000573	CcSEcCtD
Buprenorphine—Insomnia—Gabapentin—migraine	0.000115	0.000572	CcSEcCtD
Buprenorphine—Cough—Topiramate—migraine	0.000115	0.000569	CcSEcCtD
Buprenorphine—Paraesthesia—Gabapentin—migraine	0.000114	0.000568	CcSEcCtD
Buprenorphine—Convulsion—Topiramate—migraine	0.000114	0.000565	CcSEcCtD
Buprenorphine—Dyspnoea—Gabapentin—migraine	0.000114	0.000564	CcSEcCtD
Buprenorphine—Hypertension—Topiramate—migraine	0.000113	0.000563	CcSEcCtD
Buprenorphine—Somnolence—Gabapentin—migraine	0.000113	0.000562	CcSEcCtD
Buprenorphine—Hypersensitivity—Valproic Acid—migraine	0.000113	0.000562	CcSEcCtD
Buprenorphine—Feeling abnormal—Timolol—migraine	0.000113	0.000559	CcSEcCtD
Buprenorphine—Dyspepsia—Gabapentin—migraine	0.000112	0.000557	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Timolol—migraine	0.000112	0.000555	CcSEcCtD
Buprenorphine—OPRD1—brain—migraine	0.000112	0.0221	CbGeAlD
Buprenorphine—Chest pain—Topiramate—migraine	0.000112	0.000555	CcSEcCtD
Buprenorphine—Myalgia—Topiramate—migraine	0.000112	0.000555	CcSEcCtD
Buprenorphine—Arthralgia—Topiramate—migraine	0.000112	0.000555	CcSEcCtD
Buprenorphine—Anxiety—Topiramate—migraine	0.000111	0.000553	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000111	0.000551	CcSEcCtD
Buprenorphine—Decreased appetite—Gabapentin—migraine	0.000111	0.00055	CcSEcCtD
Buprenorphine—Discomfort—Topiramate—migraine	0.00011	0.000548	CcSEcCtD
Buprenorphine—Asthenia—Valproic Acid—migraine	0.00011	0.000547	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Gabapentin—migraine	0.00011	0.000546	CcSEcCtD
Buprenorphine—Fatigue—Gabapentin—migraine	0.00011	0.000545	CcSEcCtD
Buprenorphine—Dry mouth—Topiramate—migraine	0.000109	0.000543	CcSEcCtD
Buprenorphine—Constipation—Gabapentin—migraine	0.000109	0.000541	CcSEcCtD
Buprenorphine—Pain—Gabapentin—migraine	0.000109	0.000541	CcSEcCtD
Buprenorphine—Pruritus—Valproic Acid—migraine	0.000109	0.00054	CcSEcCtD
Buprenorphine—Urticaria—Timolol—migraine	0.000109	0.000539	CcSEcCtD
Buprenorphine—Body temperature increased—Timolol—migraine	0.000108	0.000537	CcSEcCtD
Buprenorphine—Abdominal pain—Timolol—migraine	0.000108	0.000537	CcSEcCtD
Buprenorphine—Confusional state—Topiramate—migraine	0.000108	0.000536	CcSEcCtD
Buprenorphine—OPRK1—brain—migraine	0.000107	0.0212	CbGeAlD
Buprenorphine—Oedema—Topiramate—migraine	0.000107	0.000532	CcSEcCtD
Buprenorphine—Infection—Topiramate—migraine	0.000106	0.000528	CcSEcCtD
Buprenorphine—Shock—Topiramate—migraine	0.000105	0.000523	CcSEcCtD
Buprenorphine—OPRM1—head—migraine	0.000105	0.0208	CbGeAlD
Buprenorphine—Diarrhoea—Valproic Acid—migraine	0.000105	0.000522	CcSEcCtD
Buprenorphine—Nervous system disorder—Topiramate—migraine	0.000105	0.000522	CcSEcCtD
Buprenorphine—Feeling abnormal—Gabapentin—migraine	0.000105	0.000521	CcSEcCtD
Buprenorphine—Tachycardia—Topiramate—migraine	0.000105	0.000519	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Gabapentin—migraine	0.000104	0.000517	CcSEcCtD
Buprenorphine—Skin disorder—Topiramate—migraine	0.000104	0.000517	CcSEcCtD
Buprenorphine—Hyperhidrosis—Topiramate—migraine	0.000104	0.000514	CcSEcCtD
Buprenorphine—Anorexia—Topiramate—migraine	0.000102	0.000507	CcSEcCtD
Buprenorphine—Dizziness—Valproic Acid—migraine	0.000102	0.000504	CcSEcCtD
Buprenorphine—Urticaria—Gabapentin—migraine	0.000101	0.000502	CcSEcCtD
Buprenorphine—Hypersensitivity—Timolol—migraine	0.000101	0.0005	CcSEcCtD
Buprenorphine—Abdominal pain—Gabapentin—migraine	0.000101	0.0005	CcSEcCtD
Buprenorphine—Body temperature increased—Gabapentin—migraine	0.000101	0.0005	CcSEcCtD
Buprenorphine—CYP2A6—cerebellum—migraine	0.000101	0.0199	CbGeAlD
Buprenorphine—OPRL1—Signaling by GPCR—TAC1—migraine	0.000101	0.00246	CbGpPWpGaD
Buprenorphine—ABCB1—blood vessel—migraine	0.0001	0.0198	CbGeAlD
Buprenorphine—OPRM1—GPCR ligand binding—HTR2B—migraine	0.0001	0.00245	CbGpPWpGaD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.0001	0.00245	CbGpPWpGaD
Buprenorphine—Hypotension—Topiramate—migraine	0.0001	0.000497	CcSEcCtD
Buprenorphine—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	9.99e-05	0.00244	CbGpPWpGaD
Buprenorphine—OPRM1—nervous system—migraine	9.98e-05	0.0197	CbGeAlD
Buprenorphine—OPRK1—GPCR downstream signaling—CALCRL—migraine	9.93e-05	0.00243	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—RAMP1—migraine	9.93e-05	0.00243	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—HTR2C—migraine	9.86e-05	0.00241	CbGpPWpGaD
Buprenorphine—Asthenia—Timolol—migraine	9.81e-05	0.000487	CcSEcCtD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	9.78e-05	0.00239	CbGpPWpGaD
Buprenorphine—Vomiting—Valproic Acid—migraine	9.77e-05	0.000485	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Topiramate—migraine	9.76e-05	0.000485	CcSEcCtD
Buprenorphine—Insomnia—Topiramate—migraine	9.69e-05	0.000481	CcSEcCtD
Buprenorphine—Rash—Valproic Acid—migraine	9.69e-05	0.000481	CcSEcCtD
Buprenorphine—Dermatitis—Valproic Acid—migraine	9.68e-05	0.00048	CcSEcCtD
Buprenorphine—Pruritus—Timolol—migraine	9.68e-05	0.00048	CcSEcCtD
Buprenorphine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	9.66e-05	0.00236	CbGpPWpGaD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	9.65e-05	0.00236	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	9.63e-05	0.00235	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	9.63e-05	0.00235	CbGpPWpGaD
Buprenorphine—Headache—Valproic Acid—migraine	9.62e-05	0.000478	CcSEcCtD
Buprenorphine—Paraesthesia—Topiramate—migraine	9.62e-05	0.000478	CcSEcCtD
Buprenorphine—OPRL1—Signaling Pathways—HTR2B—migraine	9.62e-05	0.00235	CbGpPWpGaD
Buprenorphine—OPRM1—central nervous system—migraine	9.6e-05	0.019	CbGeAlD
Buprenorphine—OPRL1—Signaling by GPCR—EDNRA—migraine	9.59e-05	0.00234	CbGpPWpGaD
Buprenorphine—Dyspnoea—Topiramate—migraine	9.55e-05	0.000474	CcSEcCtD
Buprenorphine—Somnolence—Topiramate—migraine	9.52e-05	0.000473	CcSEcCtD
Buprenorphine—OPRL1—GPCR downstream signaling—HTR7—migraine	9.51e-05	0.00232	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	9.45e-05	0.00231	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	9.43e-05	0.0023	CbGpPWpGaD
Buprenorphine—Dyspepsia—Topiramate—migraine	9.43e-05	0.000468	CcSEcCtD
Buprenorphine—Hypersensitivity—Gabapentin—migraine	9.38e-05	0.000466	CcSEcCtD
Buprenorphine—Diarrhoea—Timolol—migraine	9.36e-05	0.000465	CcSEcCtD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	9.32e-05	0.00228	CbGpPWpGaD
Buprenorphine—Decreased appetite—Topiramate—migraine	9.31e-05	0.000462	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Topiramate—migraine	9.25e-05	0.000459	CcSEcCtD
Buprenorphine—Fatigue—Topiramate—migraine	9.24e-05	0.000459	CcSEcCtD
Buprenorphine—OPRL1—Signaling by GPCR—CALCA—migraine	9.23e-05	0.00225	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	9.19e-05	0.00224	CbGpPWpGaD
Buprenorphine—Constipation—Topiramate—migraine	9.16e-05	0.000455	CcSEcCtD
Buprenorphine—Pain—Topiramate—migraine	9.16e-05	0.000455	CcSEcCtD
Buprenorphine—Asthenia—Gabapentin—migraine	9.14e-05	0.000454	CcSEcCtD
Buprenorphine—Nausea—Valproic Acid—migraine	9.12e-05	0.000453	CcSEcCtD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	9.06e-05	0.00221	CbGpPWpGaD
Buprenorphine—Dizziness—Timolol—migraine	9.04e-05	0.000449	CcSEcCtD
Buprenorphine—OPRK1—Signaling by GPCR—CALCRL—migraine	9.02e-05	0.0022	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—RAMP1—migraine	9.02e-05	0.0022	CbGpPWpGaD
Buprenorphine—Pruritus—Gabapentin—migraine	9.01e-05	0.000447	CcSEcCtD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—HTR3A—migraine	8.89e-05	0.00217	CbGpPWpGaD
Buprenorphine—Feeling abnormal—Topiramate—migraine	8.83e-05	0.000438	CcSEcCtD
Buprenorphine—OPRD1—GPCR ligand binding—HTR1B—migraine	8.82e-05	0.00215	CbGpPWpGaD
Buprenorphine—Gastrointestinal pain—Topiramate—migraine	8.76e-05	0.000435	CcSEcCtD
Buprenorphine—CYP2A6—NRF2 pathway—TGFBR2—migraine	8.74e-05	0.00213	CbGpPWpGaD
Buprenorphine—Diarrhoea—Gabapentin—migraine	8.71e-05	0.000433	CcSEcCtD
Buprenorphine—Vomiting—Timolol—migraine	8.69e-05	0.000432	CcSEcCtD
Buprenorphine—OPRL1—Signaling by GPCR—HTR7—migraine	8.64e-05	0.00211	CbGpPWpGaD
Buprenorphine—Rash—Timolol—migraine	8.62e-05	0.000428	CcSEcCtD
Buprenorphine—Dermatitis—Timolol—migraine	8.61e-05	0.000428	CcSEcCtD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	8.59e-05	0.0021	CbGpPWpGaD
Buprenorphine—Headache—Timolol—migraine	8.57e-05	0.000425	CcSEcCtD
Buprenorphine—Urticaria—Topiramate—migraine	8.51e-05	0.000423	CcSEcCtD
Buprenorphine—OPRD1—GPCR ligand binding—HTR1A—migraine	8.49e-05	0.00207	CbGpPWpGaD
Buprenorphine—Abdominal pain—Topiramate—migraine	8.47e-05	0.00042	CcSEcCtD
Buprenorphine—Body temperature increased—Topiramate—migraine	8.47e-05	0.00042	CcSEcCtD
Buprenorphine—OPRL1—Signaling Pathways—LRP1—migraine	8.47e-05	0.00207	CbGpPWpGaD
Buprenorphine—Dizziness—Gabapentin—migraine	8.42e-05	0.000418	CcSEcCtD
Buprenorphine—OPRM1—GPCR downstream signaling—RAMP1—migraine	8.39e-05	0.00205	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CALCRL—migraine	8.39e-05	0.00205	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—TAC1—migraine	8.36e-05	0.00204	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—NPS—migraine	8.36e-05	0.00204	CbGpPWpGaD
Buprenorphine—CYP2C9—cardiovascular system—migraine	8.3e-05	0.0164	CbGeAlD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	8.27e-05	0.00202	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	8.27e-05	0.00202	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—HTR1D—migraine	8.23e-05	0.00201	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—HTR2C—migraine	8.2e-05	0.002	CbGpPWpGaD
Buprenorphine—CYP2A6—brain—migraine	8.17e-05	0.0161	CbGeAlD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	8.16e-05	0.00199	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	8.14e-05	0.00199	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	8.14e-05	0.00199	CbGpPWpGaD
Buprenorphine—Nausea—Timolol—migraine	8.12e-05	0.000403	CcSEcCtD
Buprenorphine—Vomiting—Gabapentin—migraine	8.1e-05	0.000402	CcSEcCtD
Buprenorphine—Rash—Gabapentin—migraine	8.03e-05	0.000399	CcSEcCtD
Buprenorphine—Dermatitis—Gabapentin—migraine	8.02e-05	0.000398	CcSEcCtD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	7.98e-05	0.00195	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—EDNRA—migraine	7.98e-05	0.00195	CbGpPWpGaD
Buprenorphine—Headache—Gabapentin—migraine	7.98e-05	0.000396	CcSEcCtD
Buprenorphine—Hypersensitivity—Topiramate—migraine	7.89e-05	0.000392	CcSEcCtD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	7.77e-05	0.0019	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—HTR1B—migraine	7.74e-05	0.00189	CbGpPWpGaD
Buprenorphine—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	7.71e-05	0.00188	CbGpPWpGaD
Buprenorphine—Asthenia—Topiramate—migraine	7.69e-05	0.000382	CcSEcCtD
Buprenorphine—OPRD1—GPCR ligand binding—CALCA—migraine	7.68e-05	0.00188	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—HTR2B—migraine	7.65e-05	0.00187	CbGpPWpGaD
Buprenorphine—CYP2D6—brainstem—migraine	7.63e-05	0.0151	CbGeAlD
Buprenorphine—OPRM1—brain—migraine	7.62e-05	0.015	CbGeAlD
Buprenorphine—OPRM1—Signaling by GPCR—RAMP1—migraine	7.62e-05	0.00186	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CALCRL—migraine	7.62e-05	0.00186	CbGpPWpGaD
Buprenorphine—Pruritus—Topiramate—migraine	7.58e-05	0.000376	CcSEcCtD
Buprenorphine—Nausea—Gabapentin—migraine	7.56e-05	0.000376	CcSEcCtD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—migraine	7.55e-05	0.00184	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—HTR1D—migraine	7.47e-05	0.00182	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	7.46e-05	0.00182	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—HTR1A—migraine	7.45e-05	0.00182	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—TAC1—migraine	7.33e-05	0.00179	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—NPS—migraine	7.33e-05	0.00179	CbGpPWpGaD
Buprenorphine—Diarrhoea—Topiramate—migraine	7.33e-05	0.000364	CcSEcCtD
Buprenorphine—OPRK1—GPCR downstream signaling—HTR1D—migraine	7.22e-05	0.00176	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—HTR2C—migraine	7.19e-05	0.00176	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—HTR7—migraine	7.18e-05	0.00175	CbGpPWpGaD
Buprenorphine—Dizziness—Topiramate—migraine	7.08e-05	0.000352	CcSEcCtD
Buprenorphine—OPRK1—GPCR ligand binding—EDNRA—migraine	7e-05	0.00171	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	6.99e-05	0.00171	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—HTR2B—migraine	6.95e-05	0.0017	CbGpPWpGaD
Buprenorphine—Vomiting—Topiramate—migraine	6.81e-05	0.000338	CcSEcCtD
Buprenorphine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	6.76e-05	0.00165	CbGpPWpGaD
Buprenorphine—Rash—Topiramate—migraine	6.76e-05	0.000335	CcSEcCtD
Buprenorphine—Dermatitis—Topiramate—migraine	6.75e-05	0.000335	CcSEcCtD
Buprenorphine—OPRK1—GPCR ligand binding—CALCA—migraine	6.74e-05	0.00164	CbGpPWpGaD
Buprenorphine—Headache—Topiramate—migraine	6.71e-05	0.000333	CcSEcCtD
Buprenorphine—OPRK1—GPCR downstream signaling—HTR2B—migraine	6.71e-05	0.00164	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—HTR2A—migraine	6.66e-05	0.00163	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	6.61e-05	0.00161	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HTR1D—migraine	6.55e-05	0.0016	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—HTR1B—migraine	6.54e-05	0.0016	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—NOTCH4—migraine	6.49e-05	0.00159	CbGpPWpGaD
Buprenorphine—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	6.38e-05	0.00156	CbGpPWpGaD
Buprenorphine—Nausea—Topiramate—migraine	6.36e-05	0.000316	CcSEcCtD
Buprenorphine—OPRK1—GPCR ligand binding—HTR7—migraine	6.3e-05	0.00154	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—HTR1A—migraine	6.29e-05	0.00154	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—HTR1B—migraine	6.27e-05	0.00153	CbGpPWpGaD
Buprenorphine—ABCB1—trigeminal ganglion—migraine	6.2e-05	0.0122	CbGeAlD
Buprenorphine—OPRM1—GPCR ligand binding—NPS—migraine	6.2e-05	0.00151	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—TAC1—migraine	6.2e-05	0.00151	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HTR1D—migraine	6.1e-05	0.00149	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HTR2B—migraine	6.09e-05	0.00149	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—HTR2C—migraine	6.08e-05	0.00148	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CALCRL—migraine	6.08e-05	0.00148	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—RAMP1—migraine	6.08e-05	0.00148	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—HTR2A—migraine	6.05e-05	0.00148	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—HTR1A—migraine	6.03e-05	0.00147	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—NPS—migraine	5.94e-05	0.00145	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—PGR—migraine	5.94e-05	0.00145	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TAC1—migraine	5.94e-05	0.00145	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—EDNRA—migraine	5.91e-05	0.00144	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—HTR2C—migraine	5.83e-05	0.00142	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	5.79e-05	0.00141	CbGpPWpGaD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	5.72e-05	0.0014	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—CALCA—migraine	5.69e-05	0.00139	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HTR2B—migraine	5.67e-05	0.00138	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—EDNRA—migraine	5.67e-05	0.00138	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	5.65e-05	0.00138	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	5.65e-05	0.00138	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HTR1D—migraine	5.54e-05	0.00135	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—NOTCH3—migraine	5.52e-05	0.00135	CbGpPWpGaD
Buprenorphine—ABCG2—cerebellum—migraine	5.49e-05	0.0108	CbGeAlD
Buprenorphine—OPRL1—Signaling Pathways—CALCA—migraine	5.45e-05	0.00133	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—RAMP1—migraine	5.33e-05	0.0013	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CALCRL—migraine	5.33e-05	0.0013	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—HTR7—migraine	5.32e-05	0.0013	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CACNA1A—migraine	5.28e-05	0.00129	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HTR2B—migraine	5.15e-05	0.00126	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—HTR7—migraine	5.1e-05	0.00125	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—HTR2A—migraine	5.03e-05	0.00123	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—HTR1B—migraine	4.99e-05	0.00122	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	4.9e-05	0.0012	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	4.81e-05	0.00117	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—HTR1A—migraine	4.8e-05	0.00117	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—TAC1—migraine	4.73e-05	0.00115	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—NPS—migraine	4.73e-05	0.00115	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—HTR2C—migraine	4.64e-05	0.00113	CbGpPWpGaD
Buprenorphine—CYP2C8—brain—migraine	4.59e-05	0.00905	CbGeAlD
Buprenorphine—OPRD1—Signaling by GPCR—HTR1B—migraine	4.53e-05	0.00111	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—EDNRA—migraine	4.51e-05	0.0011	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CALCRL—migraine	4.5e-05	0.0011	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—RAMP1—migraine	4.5e-05	0.0011	CbGpPWpGaD
Buprenorphine—ABCB1—cardiovascular system—migraine	4.48e-05	0.00884	CbGeAlD
Buprenorphine—ABCG2—brain—migraine	4.46e-05	0.0088	CbGeAlD
Buprenorphine—OPRD1—Signaling Pathways—HTR1D—migraine	4.41e-05	0.00108	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—HTR2A—migraine	4.41e-05	0.00108	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TGFBR2—migraine	4.39e-05	0.00107	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—HTR1B—migraine	4.37e-05	0.00107	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—HTR1A—migraine	4.36e-05	0.00106	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—CALCA—migraine	4.34e-05	0.00106	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—TAC1—migraine	4.29e-05	0.00105	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—NPS—migraine	4.29e-05	0.00105	CbGpPWpGaD
Buprenorphine—CYP2D6—head—migraine	4.22e-05	0.00833	CbGeAlD
Buprenorphine—OPRD1—Signaling by GPCR—HTR2C—migraine	4.21e-05	0.00103	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—HTR1A—migraine	4.21e-05	0.00103	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CACNA1A—migraine	4.17e-05	0.00102	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—TAC1—migraine	4.14e-05	0.00101	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—NPS—migraine	4.14e-05	0.00101	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HTR2B—migraine	4.1e-05	0.001	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—EDNRA—migraine	4.09e-05	0.001	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—HTR2C—migraine	4.06e-05	0.000992	CbGpPWpGaD
Buprenorphine—CYP3A4—nervous system—migraine	4.06e-05	0.00802	CbGeAlD
Buprenorphine—OPRD1—GPCR downstream signaling—HTR7—migraine	4.06e-05	0.000991	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	4.04e-05	0.000986	CbGpPWpGaD
Buprenorphine—CYP2D6—nervous system—migraine	4e-05	0.00789	CbGeAlD
Buprenorphine—OPRK1—Signaling by GPCR—HTR1B—migraine	3.97e-05	0.000969	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—EDNRA—migraine	3.95e-05	0.000965	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CALCA—migraine	3.94e-05	0.000962	CbGpPWpGaD
Buprenorphine—CYP3A4—central nervous system—migraine	3.91e-05	0.00772	CbGeAlD
Buprenorphine—OPRK1—Signaling Pathways—HTR1D—migraine	3.87e-05	0.000945	CbGpPWpGaD
Buprenorphine—CYP2D6—central nervous system—migraine	3.85e-05	0.0076	CbGeAlD
Buprenorphine—OPRK1—Signaling by GPCR—HTR1A—migraine	3.82e-05	0.000933	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CALCA—migraine	3.81e-05	0.000929	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—NPS—migraine	3.76e-05	0.000919	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—TAC1—migraine	3.76e-05	0.000919	CbGpPWpGaD
Buprenorphine—CYP2D6—cerebellum—migraine	3.76e-05	0.00743	CbGeAlD
Buprenorphine—OPRM1—GPCR ligand binding—HTR2A—migraine	3.73e-05	0.000911	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HTR1B—migraine	3.7e-05	0.000902	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HTR2C—migraine	3.69e-05	0.000901	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—HTR7—migraine	3.69e-05	0.0009	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—migraine	3.66e-05	0.000893	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—migraine	3.66e-05	0.000893	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—LRP1—migraine	3.61e-05	0.000882	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HTR2B—migraine	3.6e-05	0.000879	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—EDNRA—migraine	3.59e-05	0.000877	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—HTR2A—migraine	3.57e-05	0.000873	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—HTR7—migraine	3.56e-05	0.000869	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HTR1A—migraine	3.56e-05	0.000869	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CACNA1A—migraine	3.54e-05	0.000865	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CACNA1A—migraine	3.51e-05	0.000857	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—NPS—migraine	3.5e-05	0.000855	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—TAC1—migraine	3.5e-05	0.000855	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CALCA—migraine	3.46e-05	0.000844	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HTR2C—migraine	3.44e-05	0.000839	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HTR1B—migraine	3.36e-05	0.000819	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—EDNRA—migraine	3.34e-05	0.000816	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR1D—migraine	3.27e-05	0.000799	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HTR7—migraine	3.23e-05	0.000789	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HTR1A—migraine	3.23e-05	0.000789	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CACNA1A—migraine	3.22e-05	0.000786	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CALCA—migraine	3.22e-05	0.000785	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—TAC1—migraine	3.18e-05	0.000777	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—NPS—migraine	3.18e-05	0.000777	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—ESR1—migraine	3.17e-05	0.000774	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—LRP1—migraine	3.17e-05	0.000774	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HTR2C—migraine	3.12e-05	0.000762	CbGpPWpGaD
Buprenorphine—CYP2D6—brain—migraine	3.06e-05	0.00603	CbGeAlD
Buprenorphine—OPRM1—Signaling Pathways—HTR2B—migraine	3.04e-05	0.000743	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—EDNRA—migraine	3.03e-05	0.000741	CbGpPWpGaD
Buprenorphine—ABCB1—head—migraine	3.03e-05	0.00599	CbGeAlD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	3.03e-05	0.000739	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HTR7—migraine	3.01e-05	0.000735	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—TNF—migraine	2.97e-05	0.000726	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CALCA—migraine	2.92e-05	0.000713	CbGpPWpGaD
Buprenorphine—ABCB1—nervous system—migraine	2.88e-05	0.00568	CbGeAlD
Buprenorphine—OPRD1—GPCR downstream signaling—HTR2A—migraine	2.84e-05	0.000694	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NOTCH4—migraine	2.77e-05	0.000677	CbGpPWpGaD
Buprenorphine—ABCB1—central nervous system—migraine	2.77e-05	0.00547	CbGeAlD
Buprenorphine—OPRM1—Signaling by GPCR—HTR7—migraine	2.73e-05	0.000667	CbGpPWpGaD
Buprenorphine—ABCB1—cerebellum—migraine	2.71e-05	0.00534	CbGeAlD
Buprenorphine—OPRM1—Signaling Pathways—LRP1—migraine	2.68e-05	0.000654	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HTR1B—migraine	2.67e-05	0.000653	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—HTR2A—migraine	2.58e-05	0.000631	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HTR1A—migraine	2.57e-05	0.000629	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CACNA1A—migraine	2.54e-05	0.00062	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TAC1—migraine	2.54e-05	0.000619	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NPS—migraine	2.54e-05	0.000619	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PGR—migraine	2.54e-05	0.000619	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—HTR2A—migraine	2.49e-05	0.000609	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HTR2C—migraine	2.49e-05	0.000607	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NOTCH4—migraine	2.43e-05	0.000594	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—EDNRA—migraine	2.42e-05	0.000591	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NOTCH3—migraine	2.36e-05	0.000576	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HTR1B—migraine	2.35e-05	0.000573	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CALCA—migraine	2.33e-05	0.000569	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HTR2A—migraine	2.26e-05	0.000553	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HTR1A—migraine	2.26e-05	0.000551	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PGR—migraine	2.22e-05	0.000543	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NPS—migraine	2.22e-05	0.000543	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TAC1—migraine	2.22e-05	0.000543	CbGpPWpGaD
Buprenorphine—ABCB1—brain—migraine	2.2e-05	0.00434	CbGeAlD
Buprenorphine—CYP2C8—Metabolism—CACNA1A—migraine	2.2e-05	0.000537	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HTR2C—migraine	2.18e-05	0.000532	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HTR7—migraine	2.18e-05	0.000532	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—EDNRA—migraine	2.12e-05	0.000518	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—HTR2A—migraine	2.11e-05	0.000515	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NOTCH3—migraine	2.07e-05	0.000505	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NOTCH4—migraine	2.05e-05	0.000502	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CALCA—migraine	2.04e-05	0.000499	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR1B—migraine	1.98e-05	0.000484	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CACNA1A—migraine	1.96e-05	0.000479	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CACNA1A—migraine	1.91e-05	0.000468	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HTR2A—migraine	1.91e-05	0.000467	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HTR7—migraine	1.91e-05	0.000466	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR1A—migraine	1.91e-05	0.000466	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PGR—migraine	1.88e-05	0.000459	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NPS—migraine	1.88e-05	0.000459	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TAC1—migraine	1.88e-05	0.000459	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TGFBR2—migraine	1.88e-05	0.000458	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR2C—migraine	1.84e-05	0.00045	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CACNA1A—migraine	1.8e-05	0.000441	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—EDNRA—migraine	1.79e-05	0.000438	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CACNA1A—migraine	1.79e-05	0.000437	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NOTCH3—migraine	1.75e-05	0.000427	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—MTHFR—migraine	1.75e-05	0.000426	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CALCA—migraine	1.73e-05	0.000421	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TGFBR2—migraine	1.64e-05	0.000402	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR7—migraine	1.61e-05	0.000394	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CACNA1A—migraine	1.53e-05	0.000373	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HTR2A—migraine	1.53e-05	0.000372	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.47e-05	0.000358	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TGFBR2—migraine	1.39e-05	0.000339	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—MTHFR—migraine	1.38e-05	0.000337	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—ESR1—migraine	1.35e-05	0.000331	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HTR2A—migraine	1.34e-05	0.000327	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—ESR1—migraine	1.19e-05	0.00029	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CACNA1A—migraine	1.18e-05	0.000288	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—MTHFR—migraine	1.17e-05	0.000286	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—MTHFR—migraine	1.16e-05	0.000284	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HTR2A—migraine	1.13e-05	0.000276	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—MTHFR—migraine	1.06e-05	0.00026	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—ESR1—migraine	1e-05	0.000245	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—MTHFR—migraine	8.39e-06	0.000205	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—MTHFR—migraine	7.27e-06	0.000178	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—MTHFR—migraine	6.49e-06	0.000158	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—MTHFR—migraine	6.33e-06	0.000155	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MTHFR—migraine	5.97e-06	0.000146	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MTHFR—migraine	5.92e-06	0.000144	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MTHFR—migraine	5.06e-06	0.000123	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MTHFR—migraine	3.9e-06	9.53e-05	CbGpPWpGaD
